Most cited papers from Celerion (United Kingdom)

Celerion (United Kingdom)

What are the most cited papers from Celerion (United Kingdom)?

The most cited paper from Celerion (United Kingdom) is "Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects" (Nathan Gale, Mike McEwan, Alison C. Eldridge et al., 2018), with 95 citations. Next come "Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD" (81) and "Nicotine pharmacokinetics of electronic cigarettes: A review of the literature" (58).

Published TypeFieldAccess

Showing 26 of 26 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects Nathan Gale, Mike McEwan, Alison C. Eldridge et al. · Nicotine & Tobacco Research Open access	17 May 2018	95
2	Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD Dave Singh, Kai Michael Beeh, Brendan Colgan et al. · Respiratory Research Open access	9 Aug 2019	81
3	Nicotine pharmacokinetics of electronic cigarettes: A review of the literature Ian M. Fearon, Alison C. Eldridge, Nathan Gale et al. · Regulatory Toxicology and Pharmacology	8 Sep 2018	58
4	Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis Mirco Govoni, Michele Bassi, Stefano Vezzoli et al. · Respiratory Research Open access	20 Mar 2020	32
5	8th GCC: Consolidated Feedback to US FDA on The 2013 Draft FDA Guidance on Bioanalytical Method Validation Joseph F. Bower et al. · Bioanalysis	Nov 2014	32
6	The Impact of N-nitrosamine Impurities on Clinical Drug Development Sabina Paglialunga, Aernout D. van Haarst · Journal of Pharmaceutical Sciences Open access	25 Jan 2023	29
7	Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding—delayed add-back onset does not improve bleeding pattern Oliver Pohl, Line Marchand, David Bell et al. · Reproductive Sciences	25 Feb 2020	27
8	The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development Susan Reijntjes, Muna Albayaty, JAMES A. BUSH et al. · Frontiers in Pharmacology Open access	19 Nov 2018	26
9	Rifampin Drug–Drug–Interaction Studies: Reflections on the Nitrosamine Impurities Issue Aernout D. van Haarst, Stephen W. Smith, Clare Garvin et al. · Clinical Pharmacology & Therapeutics Open access	20 May 2022	24
10	COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition Dave Singh, Henrik Watz, Kai Michael Beeh et al. · European Respiratory Journal Open access	27 Apr 2020	24
11	Envelope domain analysis of measured time domain voltage and current waveforms provide for improved understanding of factors effecting linearity David John Williams, J.G. Leckey, P.J. Tasker Conference paper	27 Aug 2003	22
12	2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines ( PART 2 – Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Bind Olga Kholmanskikh et al. · Bioanalysis Open access	17 Apr 2024	17
13	Adjusting for Patient Crossover in Clinical Trials Using External Data: A Case Study of Lenalidomide for Advanced Multiple Myeloma K. Jack Ishak, J. Jaime, Mark Trehane Drayson et al. · Value in Health Open access	Jul 2011	14
14	Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestion David A. Dworaczyk, Allen Gerhard Hunt, Mike Di Spirito et al. · Annals of Allergy Asthma & Immunology Open access	7 May 2024	12
15	Innovative Approaches to Optimize Clinical Transporter Drug–Drug Interaction Studies Sabina Paglialunga, Natacha Benrimoh, Aernout D. van Haarst · Pharmaceutics Open access	26 Jul 2024	9
16	Should You Run a Dedicated TQT Study? Sponsor and Regulatory Considerations on Substitution Pathways to Assess QT Liability Robert M. Lester, Caroline Engel, Aernout D. van Haarst et al. · Clinical Pharmacology & Therapeutics Open access	2 May 2024	9
17	Techniques for Hyaluronidase-Facilitated Subcutaneous Fluid Administration With Recombinant Human Hyaluronidase Sandra M. Connolly, Helen Korzemba, George Harb et al. · Journal of Infusion Nursing	Sep 2011	6
18	nanoCLAMP potently neutralizes SARS-CoV-2 and protects K18-hACE2 mice from infection Quentin Pagneux, Nathalie Garnier, Manon Fabregue et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	3 Apr 2023	4
19	13.2mg Intranasal Epinephrine Spray Demonstrates Comparable PK/PD and Safety to 0.3mg Epinephrine Autoinjector David Dworaczyk, Allen Gerhard Hunt · Journal of Allergy and Clinical Immunology	Feb 2023	4
20	The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges Shahzadgai Khan, Muna Albayaty, JAMES A. BUSH et al. · Frontiers in Pharmacology Open access	19 Nov 2020	4
21	Pharmacokinetic and Pharmacodynamic Effects of Intranasal Epinephrine Versus Intramuscular Epinephrine in Adults David Dworaczyk, Allen Hunt · Journal of Allergy and Clinical Immunology	Feb 2020	4
22	126 A phase 1 clinical study of CTX-4430 in cystic fibrosis patients Eric B. Springman, Ralph Grosswald, Edward E. Philpot et al. · Journal of Cystic Fibrosis Open access	Jun 2015	4
23	First-in-human study for londamocitinib (AZD4604), an inhaled selective JAK1 inhibitor Tina Jellesmark Jensen, Camille Riff, Julia Lund et al. · Journal of Allergy and Clinical Immunology Open access	12 Jan 2026	3
24	HBT active antenna as a self-oscillating Doppler sensor M.J. Kelly, Vincent Fusco, J.A.C. Stewart et al. · IEE Proceedings - Microwaves Antennas and Propagation	2000	1
25	Safety and Pharmacokinetics (PK) of BLU-808 Following Oral Dosing in Healthy Volunteers Anitha Suram, Ivan Lee, Huilan Yao et al. · Journal of Allergy and Clinical Immunology	Feb 2025	0
26	COVID-19 and Re-Commencement of Early Phase Clinical Trials in Respiratory Medicine Aernout D. van Haarst · International Journal of Pulmonary & Respiratory Sciences Open access	28 Jul 2021	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.